These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7699497)

  • 1. Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders.
    Fu K; Ma X; Zhang Z; Chen W
    J Oral Maxillofac Surg; 1995 Apr; 53(4):424-6. PubMed ID: 7699497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor necrosis factor in synovial fluids of temporomandibular joint dysfunction syndrome].
    Fu KY; Ma XC; Zhang ZK
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Sep; 29(5):269-71, 319-20. PubMed ID: 7743857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the cytokine profiles of the synovial fluid in a normal temporomandibular joint: preliminary study.
    Kim YK; Kim SG; Kim BS; Lee JY; Yun PY; Bae JH; Oh JS; Ahn JM; Kim JS; Lee SY
    J Craniomaxillofac Surg; 2012 Dec; 40(8):e337-41. PubMed ID: 22425498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders.
    Takahashi T; Kondoh T; Fukuda M; Yamazaki Y; Toyosaki T; Suzuki R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Feb; 85(2):135-41. PubMed ID: 9503445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclastogenesis inhibitory factor/osteoprotegerin in synovial fluid from patients with temporomandibular disorders.
    Kaneyama K; Segami N; Nishimura M; Sato J; Suzuki T; Fujimura K
    Int J Oral Maxillofac Surg; 2003 Aug; 32(4):404-7. PubMed ID: 14505625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory cytokines in temporomandibular joint synovial fluid before and after arthrocentesis.
    Gulen H; Ataoglu H; Haliloglu S; Isik K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):e1-4. PubMed ID: 19426899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha levels in the synovial fluid of patients with temporomandibular joint internal derangement.
    Güven O; Tekin U; Salmanoğlu B; Kaymak E
    J Craniomaxillofac Surg; 2015 Jan; 43(1):102-5. PubMed ID: 25465487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporomandibular joint pain: relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-alpha.
    Emshoff R; Puffer P; Rudisch A; Gassner R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):442-9. PubMed ID: 11027380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 beta, interleukin-6, and tissue inhibitor of metalloproteinase-1 in the synovial fluid of the temporomandibular joint with respect to cartilage destruction.
    Shinoda C; Takaku S
    Oral Dis; 2000 Nov; 6(6):383-90. PubMed ID: 11355271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant capacity of synovial fluid in the temporomandibular joint correlated with radiological morphology of temporomandibular disorders.
    Ishimaru K; Ohba S; Yoshimura H; Matsuda S; Ishimaru J; Sano K
    Br J Oral Maxillofac Surg; 2015 Feb; 53(2):114-20. PubMed ID: 25457626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble tumour necrosis factor receptors in synovial fluids from temporomandibular joints with painful anterior disc displacement without reduction and osteoarthritis.
    Uehara J; Kuboki T; Fujisawa T; Kojima S; Maekawa K; Yatani H
    Arch Oral Biol; 2004 Feb; 49(2):133-42. PubMed ID: 14693207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosaminoglycan components in temporomandibular joint synovial fluid as markers of joint pathology.
    Shibata T; Murakami KI; Kubota E; Maeda H
    J Oral Maxillofac Surg; 1998 Feb; 56(2):209-13. PubMed ID: 9461147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of nitric oxide in synovial fluid from patients with temporomandibular disorders.
    Takahashi T; Kondoh T; Kamei K; Seki H; Fukuda M; Nagai H; Takano H; Yamazaki Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Nov; 82(5):505-9. PubMed ID: 8936513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-expression of interleukin-1beta and tumor necrosis factor alpha in synovial tissues and synovial fluids of temporomandibular joint with internal derangement: comparison with histological grading of synovial inflammation.
    Suzuki T; Segami N; Nishimura M; Nojima T
    J Oral Pathol Med; 2002 Oct; 31(9):549-57. PubMed ID: 12269994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha in temporomandibular joint synovial fluid predicts treatment effects on pain by intra-articular glucocorticoid treatment.
    Fredriksson L; Alstergren P; Kopp S
    Mediators Inflamm; 2006; 2006(6):59425. PubMed ID: 17392588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between arthroscopic diagnosis of temporomandibular joint osteoarthritis and synovial fluid nitric oxide levels.
    Takahashi T; Kondoh T; Ohtani M; Homma H; Fukuda M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Aug; 88(2):129-36. PubMed ID: 10468453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders.
    Kaneyama K; Segami N; Nishimura M; Suzuki T; Sato J
    Br J Oral Maxillofac Surg; 2002 Oct; 40(5):418-23. PubMed ID: 12379189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
    Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-beta1 in synovial fluid aspirates of patients with temporomandibular disorders.
    Fang PK; Ma XC; Ma DL; Fu KY
    J Oral Maxillofac Surg; 1999 Aug; 57(8):922-8; discussion 928-9. PubMed ID: 10437719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A decrease in the molecular weight of hyaluronic acid in synovial fluid from patients with temporomandibular disorders.
    Takahashi T; Tominaga K; Takano H; Ariyoshi W; Habu M; Fukuda J; Maeda H
    J Oral Pathol Med; 2004 Apr; 33(4):224-9. PubMed ID: 15061710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.